Advancell raises $315M to power global isotope strategy
· tamra sami
AI Briefing
- • Advancell raises $315M in oversubscribed series D round for global isotope strategy.
- • Funding supports late-stage clinical development and isotope supply infrastructure.
- • Company aims to become fully integrated global radiopharma developer.
Source Summary
Advancell Co. Ltd. has raised an oversubscribed $315 million series D round to accelerate its push to become a fully integrated global radiopharma developer, funding late-stage clinical development alongside isotope supply and manufacturing infrastructure.
Advertisement